Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity

Kang TB, Park HI, Suh Y, Zhao YG, Tschesche H, Sang QXA (2002)
JOURNAL OF BIOLOGICAL CHEMISTRY 277(50): 48514-48522.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ;
Abstract / Bemerkung
We investigated the regulation of the proteolytic activity of human adamalysin 19 (a disintegrin and metalloproteinase 19, hADAM19). It was processed at Glu(586) (P1)-Ser(587)(P1') site in the cysteine-rich domain as shown by protein N-terminal sequencing. This truncation was autolytic as illustrated by its R199A/R200A or E346A mutation that prevented the zymogen activation by furin or abolished the catalytic activity. Reagents that block furin-mediated activation of pro-hADAM19, decRVKR-CMK, A23187, and brefeldin A abrogated this processing. The sizes of the side chains of the P1 and P1' residues are critical for the processing of hADAM19. The amount of processing product in the E586Q or S587A mutant with a side chain almost the same size as that in the wild type was almost equal. Conversely, very little processing was observed when the size of the side chain was changed significantly, such as in the E586A, E586G, or S587F mutants. Two mutants with presumably subtle structural distinctions from wild type hADAM19, E586D and S587T, displayed rare or little processing and had very low capacities to cleave alpha2-macroglobulin and a peptide substrate. Therefore, this processing is necessary for hADAM19 to exert its proteolytic activities. Moreover, a new peptide substrate, Ac-RPLE-SNAV, which is identical to the processing site sequence, was cleaved at the E-S bond by soluble hADAM19 containing the catalytic and disintegrin domains. This enzyme cleaved the substrate with K-m, k(cat), and k(cat)/K-m of 2.0 mm, 2.4/min, and 1200 M-1 min(-1), respectively, using a fluorescamine assay. Preliminary studies showed that a protein kinase C activator, phorbol 12-myristate 13-acetate, promoted the cellular processing of hADAM19; however, three calmodulin antagonists, trifluoperazine, W7, and calmidazolium, impaired this cleavage, indicating complex signal pathways may be involved in the processing.
Erscheinungsjahr
Zeitschriftentitel
JOURNAL OF BIOLOGICAL CHEMISTRY
Band
277
Zeitschriftennummer
50
Seite
48514-48522
ISSN
eISSN
PUB-ID

Zitieren

Kang TB, Park HI, Suh Y, Zhao YG, Tschesche H, Sang QXA. Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY. 2002;277(50):48514-48522.
Kang, T. B., Park, H. I., Suh, Y., Zhao, Y. G., Tschesche, H., & Sang, Q. X. A. (2002). Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(50), 48514-48522. doi:10.1074/jbc.M208961200
Kang, T. B., Park, H. I., Suh, Y., Zhao, Y. G., Tschesche, H., and Sang, Q. X. A. (2002). Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY 277, 48514-48522.
Kang, T.B., et al., 2002. Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(50), p 48514-48522.
T.B. Kang, et al., “Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, 2002, pp. 48514-48522.
Kang, T.B., Park, H.I., Suh, Y., Zhao, Y.G., Tschesche, H., Sang, Q.X.A.: Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. JOURNAL OF BIOLOGICAL CHEMISTRY. 277, 48514-48522 (2002).
Kang, TB, Park, HI, Suh, Y, Zhao, YG, Tschesche, Harald, and Sang, QXA. “Autolytic processing at Glu(586)-Ser(587) within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity”. JOURNAL OF BIOLOGICAL CHEMISTRY 277.50 (2002): 48514-48522.

19 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.
Weerasekera L, Rudnicka C, Sang QX, Curran JE, Johnson MP, Moses EK, Göring HH, Blangero J, Hricova J, Schlaich M, Matthews VB., Mediators Inflamm 2017(), 2017
PMID: 28265178
SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.
Tien WS, Chen JH, Wu KP., BMC Bioinformatics 18(suppl 3), 2017
PMID: 28361715
Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.
Hoyne G, Rudnicka C, Sang QX, Roycik M, Howarth S, Leedman P, Schlaich M, Candy P, Matthews V., BMC Cancer 16(), 2016
PMID: 26912236
Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.
Masuyer G, Douglas RG, Sturrock ED, Acharya KR., Sci Rep 5(), 2015
PMID: 26403559
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases.
Franzè E, Caruso R, Stolfi C, Sarra M, Cupi ML, Ascolani M, Sedda S, Antenucci C, Ruffa A, Caprioli F, MacDonald TT, Pallone F, Monteleone G., Inflamm Bowel Dis 19(3), 2013
PMID: 23429442
ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.
Suh J, Choi SH, Romano DM, Gannon MA, Lesinski AN, Kim DY, Tanzi RE., Neuron 80(2), 2013
PMID: 24055016
Identification of a thrombin cleavage site and a short form of ADAMTS-18.
Wang J, Zhang W, Yi Z, Wang S, Li Z., Biochem Biophys Res Commun 419(4), 2012
PMID: 22386991
In silico analysis of neuregulin 1 evolution in vertebrates.
Chou CF, Ozaki M., Biosci Rep 30(4), 2010
PMID: 19681757
ADAM19 autolysis is activated by LPS and promotes non-classical secretion of cysteine-rich protein 2.
Tanabe C, Hotoda N, Sasagawa N, Futai E, Komano H, Ishiura S., Biochem Biophys Res Commun 396(4), 2010
PMID: 20460109
ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.
Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Konietzko U, Reiss K, Maes E, Snellinx A, Serneels L, Nyabi O, Annaert W, Saftig P, Hartmann D, De Strooper B., J Biol Chem 284(17), 2009
PMID: 19213735
(Make) stick and cut loose--disintegrin metalloproteases in development and disease.
Tousseyn T, Jorissen E, Reiss K, Hartmann D., Birth Defects Res C Embryo Today 78(1), 2006
PMID: 16622847
ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration.
Melenhorst WB, van den Heuvel MC, Timmer A, Huitema S, Bulthuis M, Timens W, van Goor H., Kidney Int 70(7), 2006
PMID: 16900093
Expression of adamalysin 19/ADAM19 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy.
Wang HX, Zhao YG, Wang HM, Yang Q, Lin HY, Sang QX, Zhu C., Mol Hum Reprod 11(6), 2005
PMID: 15901844
Catalytic activity of human ADAM33.
Zou J, Zhu F, Liu J, Wang W, Zhang R, Garlisi CG, Liu YH, Wang S, Shah H, Wan Y, Umland SP., J Biol Chem 279(11), 2004
PMID: 14676211
ADAM proteins in the brain.
Novak U., J Clin Neurosci 11(3), 2004
PMID: 14975408
Isolation and embryonic expression of avian ADAM 12 and ADAM 19.
Lewis SL, Farlie PG, Newgreen DF., Gene Expr Patterns 5(1), 2004
PMID: 15533821
ADAM23 is a cell-surface glycoprotein expressed by central nervous system neurons.
Goldsmith AP, Gossage SJ, ffrench-Constant C., J Neurosci Res 78(5), 2004
PMID: 15505805

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 12393862
PubMed | Europe PMC

Suchen in

Google Scholar